381 related articles for article (PubMed ID: 32694169)
1. Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?
Ladikou EE; Sivaloganathan H; Milne KM; Arter WE; Ramasamy R; Saad R; Stoneham SM; Philips B; Eziefula AC; Chevassut T
Clin Med (Lond); 2020 Sep; 20(5):e178-e182. PubMed ID: 32694169
[TBL] [Abstract][Full Text] [Related]
2. Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19.
Marco A; Marco P
J Thromb Thrombolysis; 2021 Aug; 52(2):497-503. PubMed ID: 33866481
[TBL] [Abstract][Full Text] [Related]
3. Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes.
Grobler C; Maphumulo SC; Grobbelaar LM; Bredenkamp JC; Laubscher GJ; Lourens PJ; Steenkamp J; Kell DB; Pretorius E
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708334
[TBL] [Abstract][Full Text] [Related]
4. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.
Goshua G; Pine AB; Meizlish ML; Chang CH; Zhang H; Bahel P; Baluha A; Bar N; Bona RD; Burns AJ; Dela Cruz CS; Dumont A; Halene S; Hwa J; Koff J; Menninger H; Neparidze N; Price C; Siner JM; Tormey C; Rinder HM; Chun HJ; Lee AI
Lancet Haematol; 2020 Aug; 7(8):e575-e582. PubMed ID: 32619411
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients With COVID-19.
Berger JS; Kunichoff D; Adhikari S; Ahuja T; Amoroso N; Aphinyanaphongs Y; Cao M; Goldenberg R; Hindenburg A; Horowitz J; Parnia S; Petrilli C; Reynolds H; Simon E; Slater J; Yaghi S; Yuriditsky E; Hochman J; Horwitz LI
Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2539-2547. PubMed ID: 32840379
[TBL] [Abstract][Full Text] [Related]
6. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.
Artifoni M; Danic G; Gautier G; Gicquel P; Boutoille D; Raffi F; Néel A; Lecomte R
J Thromb Thrombolysis; 2020 Jul; 50(1):211-216. PubMed ID: 32451823
[TBL] [Abstract][Full Text] [Related]
7. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F;
Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170
[TBL] [Abstract][Full Text] [Related]
8. Computed tomography characterization and outcome evaluation of COVID-19 pneumonia complicated by venous thromboembolism.
Meiler S; Hamer OW; Schaible J; Zeman F; Zorger N; Kleine H; Rennert J; Stroszczynski C; Poschenrieder F
PLoS One; 2020; 15(11):e0242475. PubMed ID: 33211737
[TBL] [Abstract][Full Text] [Related]
9. Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality.
Philippe A; Chocron R; Gendron N; Bory O; Beauvais A; Peron N; Khider L; Guerin CL; Goudot G; Levasseur F; Peronino C; Duchemin J; Brichet J; Sourdeau E; Desvard F; Bertil S; Pene F; Cheurfa C; Szwebel TA; Planquette B; Rivet N; Jourdi G; Hauw-Berlemont C; Hermann B; Gaussem P; Mirault T; Terrier B; Sanchez O; Diehl JL; Fontenay M; Smadja DM
Angiogenesis; 2021 Aug; 24(3):505-517. PubMed ID: 33449299
[TBL] [Abstract][Full Text] [Related]
10. Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019.
Maatman TK; Jalali F; Feizpour C; Douglas A; McGuire SP; Kinnaman G; Hartwell JL; Maatman BT; Kreutz RP; Kapoor R; Rahman O; Zyromski NJ; Meagher AD
Crit Care Med; 2020 Sep; 48(9):e783-e790. PubMed ID: 32459672
[TBL] [Abstract][Full Text] [Related]
11. ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer.
Pépin M; Kleinjan A; Hajage D; Büller HR; Di Nisio M; Kamphuisen PW; Salomon L; Veyradier A; Stepanian A; Mahé I
J Thromb Haemost; 2016 Feb; 14(2):306-15. PubMed ID: 26589836
[TBL] [Abstract][Full Text] [Related]
12. D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.
Eljilany I; Elzouki AN
Vasc Health Risk Manag; 2020; 16():455-462. PubMed ID: 33223833
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic risk in COVID-19: a case series and case-control study.
Stoneham SM; Milne KM; Nuttall E; Frew GH; Sturrock BR; Sivaloganathan H; Ladikou EE; Drage S; Phillips B; Chevassut TJ; Eziefula AC
Clin Med (Lond); 2020 Jul; 20(4):e76-e81. PubMed ID: 32423903
[TBL] [Abstract][Full Text] [Related]
14. [Estimation of venous thromboembolism risk with thrombotic biomarkers in cancer patients].
Jianlong M; Diansheng Z; Jing R
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):283-9. PubMed ID: 26462893
[TBL] [Abstract][Full Text] [Related]
15. Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications.
Voicu S; Delrue M; Chousterman BG; Stépanian A; Bonnin P; Malissin I; Deye N; Neuwirth M; Ketfi C; Mebazaa A; Siguret V; Mégarbane B
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9161-9168. PubMed ID: 32965009
[TBL] [Abstract][Full Text] [Related]
16. Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far?
Tal S; Spectre G; Kornowski R; Perl L
Acta Haematol; 2020; 143(5):417-424. PubMed ID: 32396903
[TBL] [Abstract][Full Text] [Related]
17. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.
Lip GY; Lowe GD; Rumley A; Dunn FG
Br Heart J; 1995 Jun; 73(6):527-33. PubMed ID: 7626351
[TBL] [Abstract][Full Text] [Related]
18. [Predictive value of von Willebrand factor for venous thromboembolism in critically ill patients based on propensity score matching].
Yue J; Wan L; Wang G; Zhang R; Zhang X; Liu O; Yu X; Huang Q; Ren Z
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Jan; 36(1):73-77. PubMed ID: 38404276
[TBL] [Abstract][Full Text] [Related]
19. High factor VIII, von Willebrand factor, and fibrinogen levels and risk of venous thromboembolism in blacks and whites.
Payne AB; Miller CH; Hooper WC; Lally C; Austin HD
Ethn Dis; 2014; 24(2):169-74. PubMed ID: 24804362
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Venous Thromboembolism Risks Between COVID-19 Pneumonia and Community-Acquired Pneumonia Patients.
Mei F; Fan J; Yuan J; Liang Z; Wang K; Sun J; Guan W; Huang M; Li Y; Zhang WW
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2332-2337. PubMed ID: 32628040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
